• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

ACP recommends weight loss and CPAP for obstructive sleep apnea

byAndrew Bishara
September 24, 2013
in Chronic Disease, Gastroenterology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. A new clinical practice guideline from the American College of Physicians (ACP) recommends weight loss and continuous positive airway pressure (CPAP) treatment for management of obstructive sleep apnea (OSA) (strong recommendation).

2. The guideline also recommends mandibular advancement devices (MADs) as an alternative to CPAP (weak recommendation).

Evidence Rating Level: 2 (Good) 

Study Rundown: OSA is a disease associated with significant morbidity and mortality.   The ACP recently performed a systematic review to establish clinical practice guidelines for treatment of OSA.  The clinical outcomes identified for the the review were cardiovascular disease, type-II diabetes mellitus, and death, as well as the measures of sleep studies, cardiovascular status, diabetic status, and quality of life.  The ACP released three main recommendations based on this review.  (1) First, the ACP found evidence to supporting weight loss as an intervention to improve the symptoms of OSA.  Despite the low-quality of this evidence, given hat weight loss is also associated with many other health benefits other than OSA, the ACP recommends that all over-weight and obese patients with OSA should be encouraged to lose weight.  (2) Regarding, CPAP use, the ACP found moderate-quality evidence demonstrating CPAP was more effective than sham CPAP, despite the lack of randomized trials investigating long-term clinical outcomes and inconclusive changes to quality of life.  Furthermore, fixed, auto, and C-Flex CPAP were all found to have only small differences in overall efficacy.  Thus, from this evidence, the ACP recommends CPAP as initial therapy for patients diagnosed with OSA.  (3) The review of MADs found good evidence supporting its use, although the treatment effect by CPAP was more substantial.  Therefore, if patients suffer adverse effects from CPAP, the ACP weakly recommends MADs as an alternative treatment.

Click to read the study, published today in the Annals of Internal Medicine

RELATED REPORTS

Tirzepatide reduces obstructive sleep apnea symptoms and associated risks

#VisualAbstract: Tirzepatide Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity

Atypical deglutition associated with obstructive sleep apnea in children

Relevant Reading: Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea

In-Depth [systematic review]: The ACP examined three studies investigating the effects of weight-loss intervention, all of which showed improved patient Apnea Hypopnea Index (AHI) [between -4 to -23 events/hour].  Two studies reported changes in Epworth Sleepiness Scale, with only one showing a significant difference in the weight loss group.  However, one study found that a low-calorie diet increased the rate of an OSA cure, with an adjusted odds ratio of 4.2.  Despite the low quality of the evidence, the ACP strongly recommended weight loss for OSA patients.  To review the efficacy of CPAP treatment, 22 studies were evaluated.  Among these, there was moderate evidence supporting reduced AHI, increased ESS, and increased minimum oxygen saturation when compared to controls.  Quality of life changes could not be determined, as the ten studies that observed changes used differing sub-scales, with most showing no significant improvement due to CPAP.  Another study showed no difference in cardiovascular events in those treated with CPAP, but one did demonstrate an increase in the NIH stroke scale in those treated with CPAP (2.3/10 vs 1.4/10 for controls).  Seven out of eight observational studies, but no RCTs, showed a significant reduction in mortality associated with CPAP therapy.  Five trials showed that MADs reduced AHI and increased minimum oxygen saturation when compared to no treatment, though ten additional studies showed improved efficacy of CPAP vs. MAD treatment.  One study did demonstrate increased adherence to MAD when compared to CPAP.  Other alternatives, such as positional therapy and surgical options, did not have sufficient evidence to merit a recommendation.  Overall, because of its efficacy over no treatment, the ACP recommended MAD for patients with adverse effects to CPAP treatment.

By Sai Folmsbee and Aimee Li, MD

More from this author: Combination therapy with tofacitinib improves response in rheumatoid arthritis USPTF recommends tobacco counseling for adolescents by primary care physicians Peer-delivered education through social networking increases home-based HIV testing

 

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: sleep apnea
Previous Post

USPSTF recommends use of risk-reducing medications for breast cancer

Next Post

Recommendations for intrapartum management of TOLAC

RelatedReports

Admission may not be needed following sleep apnea surgery
Chronic Disease

Tirzepatide reduces obstructive sleep apnea symptoms and associated risks

October 10, 2024
#VisualAbstract: Tirzepatide Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity
StudyGraphics

#VisualAbstract: Tirzepatide Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity

July 5, 2024
Parents with poor sleep quality report sleep problems in kids
Psychiatry

Atypical deglutition associated with obstructive sleep apnea in children

March 15, 2024
Wide-ranging health benefits from outdoor adult walking groups
Lifestyle

Several exercise modalities improve sleep quality in patients with sleep disorders

December 1, 2023
Next Post
Antepartum and intrapartum events both linked to neonatal HIE

Recommendations for intrapartum management of TOLAC

Androgen deprivation in prostate cancer: intermittent may compromise survival

Healthier lifestyle linked with longer telomeres in benign prostate cancer

Classics Series, Landmark Trials in Medicine

The CARE trial: Statins in coronary artery disease [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Breast cancer survivors may have a lower risk of Alzheimer’s dementia
  • Evaluating scar outcomes in pediatric burn patients following skin grafting 
  • Novel inhibitory antibody, MAR001, lowers triglycerides and remnant cholesterol in humans
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.